{
  "investigation": {
    "id": "OSD-812",
    "title": "Simulated microgravity impairs human NK cell cytotoxic activity against space radiation-relevant leukemic cells.",
    "description": "Natural killer (NK) cells are an important first-line of defense against malignant cells. Because of the potential for increased cancer risk from astronaut exposure to space radiation, we determined whether microgravity present during spaceflight affects the body's defenses against leukemogenesis.",
    "mission": {
      "name": "",
      "start_date": "",
      "end_date": "",
      "link": ""
    },
    "project": {
      "identifier": "Simulated_Microgravity",
      "title": "",
      "type": "Ground Study",
      "link": "",
      "funding": "This work was supported by Grant NNX17AE49G from NASA Space Biology and by the NASA Translational Research Institute for Space Health (TRISH) through Cooperative Agreement NNX16AO69A. B.M.K. and J.H.D. are supported by T32 pre-doctoral fellow positions through NIH NIBIB 2T32EB014836.",
      "managing_center": ""
    },
    "protocols": [
      "growth protocol",
      "treatment protocol",
      "sample collection",
      "Nucleic Acid Extraction",
      "Library Construction",
      "Nucleic Acid Sequencing",
      "GeneLab raw data processing protocol"
    ],
    "publications": [
      {
        "title": "Simulated microgravity impairs human NK cell cytotoxic activity against space radiation-relevant leukemic cells.",
        "doi": "10.1038/s41526-024-00424-1",
        "authors": [
          "Kuhlman BM",
          "Diaz JH",
          "Simon T",
          "Reeves KD",
          "Walker SJ",
          "Atala A",
          "Almeida-Porada G",
          "Porada CD."
        ],
        "summary": "Simulated microgravity impairs human NK cell cytotoxic activity against space radiation-relevant leukemic cells. — 10.1038/s41526-024-00424-1"
      }
    ],
    "factors": [
      "Microgravity Simulation"
    ],
    "contacts": [
      {
        "first_name": "Bradford M",
        "last_name": "Kuhlman",
        "role": "Author",
        "email": "cporada@wakehealth.edu"
      },
      {
        "first_name": "Jonathan H",
        "last_name": "Diaz",
        "role": "Author",
        "email": ""
      },
      {
        "first_name": "Trang",
        "last_name": "Simon",
        "role": "Author",
        "email": ""
      },
      {
        "first_name": "Kimberly D",
        "last_name": "Reeves",
        "role": "Author",
        "email": ""
      },
      {
        "first_name": "Stephen J",
        "last_name": "Walker",
        "role": "Author",
        "email": ""
      },
      {
        "first_name": "Anthony",
        "last_name": "Atala",
        "role": "Author",
        "email": ""
      },
      {
        "first_name": "Graça",
        "last_name": "Almeida-Porada",
        "role": "Author",
        "email": ""
      },
      {
        "first_name": "Christopher D",
        "last_name": "Porada",
        "role": "conceptualization role",
        "email": ""
      }
    ]
  },
  "study": {
    "samples": [
      {
        "sample_name": "GSM8078929",
        "characteristics": {
          "Organism": "Homo sapiens",
          "Donor ID": "Donor 2",
          "Sex": "Male",
          "age": "25–35",
          "Material Type": "Cells, Cultured",
          "cell type": "Killer Cells, Natural",
          "cell culture": "Primary Cell Culture",
          "tissue": "Peripheral Blood",
          "cell source": "tissue donor"
        },
        "factors": {
          "Microgravity Simulation": "1G by RWV"
        },
        "parameters": {
          "Growth Medium": "NK MACS® Medium (Miltenyi Biotech, Auburn, CA, USA), supplemented with 5% Human AB Serum (Corning Life Sciences, Durham, NC, USA) and 500 IU/mL Human Recombinant IL-2 (StemCell Technologies, Vancouver, Canada)",
          "Cell Isolation Kit": "human NK Cell Isolation Kit (MACS - Miltenyi Biotec)",
          "Growth Property": "Suspension Culture",
          "time": "24",
          "Culture Vessel": "Synthecon’s Rotating Cell Culture System (RCCS) in conjunction with High Aspect Ratio Vessels (HARVs)",
          "Sample Preservation Method": "",
          "Sample Storage Temperature": ""
        },
        "comments": {}
      },
      {
        "sample_name": "GSM8078930",
        "characteristics": {
          "Organism": "Homo sapiens",
          "Donor ID": "Donor 2",
          "Sex": "Male",
          "age": "25–35",
          "Material Type": "Cells, Cultured",
          "cell type": "Killer Cells, Natural",
          "cell culture": "Primary Cell Culture",
          "tissue": "Peripheral Blood",
          "cell source": "tissue donor"
        },
        "factors": {
          "Microgravity Simulation": "uG by RWV"
        },
        "parameters": {
          "Growth Medium": "NK MACS® Medium (Miltenyi Biotech, Auburn, CA, USA), supplemented with 5% Human AB Serum (Corning Life Sciences, Durham, NC, USA) and 500 IU/mL Human Recombinant IL-2 (StemCell Technologies, Vancouver, Canada)",
          "Cell Isolation Kit": "human NK Cell Isolation Kit (MACS - Miltenyi Biotec)",
          "Growth Property": "Suspension Culture",
          "time": "24",
          "Culture Vessel": "Synthecon’s Rotating Cell Culture System (RCCS) in conjunction with High Aspect Ratio Vessels (HARVs)",
          "Sample Preservation Method": "",
          "Sample Storage Temperature": ""
        },
        "comments": {}
      },
      {
        "sample_name": "GSM8078931",
        "characteristics": {
          "Organism": "Homo sapiens",
          "Donor ID": "Donor 3",
          "Sex": "Male",
          "age": "25–35",
          "Material Type": "Cells, Cultured",
          "cell type": "Killer Cells, Natural",
          "cell culture": "Primary Cell Culture",
          "tissue": "Peripheral Blood",
          "cell source": "tissue donor"
        },
        "factors": {
          "Microgravity Simulation": "1G by RWV"
        },
        "parameters": {
          "Growth Medium": "NK MACS® Medium (Miltenyi Biotech, Auburn, CA, USA), supplemented with 5% Human AB Serum (Corning Life Sciences, Durham, NC, USA) and 500 IU/mL Human Recombinant IL-2 (StemCell Technologies, Vancouver, Canada)",
          "Cell Isolation Kit": "human NK Cell Isolation Kit (MACS - Miltenyi Biotec)",
          "Growth Property": "Suspension Culture",
          "time": "24",
          "Culture Vessel": "Synthecon’s Rotating Cell Culture System (RCCS) in conjunction with High Aspect Ratio Vessels (HARVs)",
          "Sample Preservation Method": "",
          "Sample Storage Temperature": ""
        },
        "comments": {}
      },
      {
        "sample_name": "GSM8078932",
        "characteristics": {
          "Organism": "Homo sapiens",
          "Donor ID": "Donor 3",
          "Sex": "Male",
          "age": "25–35",
          "Material Type": "Cells, Cultured",
          "cell type": "Killer Cells, Natural",
          "cell culture": "Primary Cell Culture",
          "tissue": "Peripheral Blood",
          "cell source": "tissue donor"
        },
        "factors": {
          "Microgravity Simulation": "uG by RWV"
        },
        "parameters": {
          "Growth Medium": "NK MACS® Medium (Miltenyi Biotech, Auburn, CA, USA), supplemented with 5% Human AB Serum (Corning Life Sciences, Durham, NC, USA) and 500 IU/mL Human Recombinant IL-2 (StemCell Technologies, Vancouver, Canada)",
          "Cell Isolation Kit": "human NK Cell Isolation Kit (MACS - Miltenyi Biotec)",
          "Growth Property": "Suspension Culture",
          "time": "24",
          "Culture Vessel": "Synthecon’s Rotating Cell Culture System (RCCS) in conjunction with High Aspect Ratio Vessels (HARVs)",
          "Sample Preservation Method": "",
          "Sample Storage Temperature": ""
        },
        "comments": {}
      }
    ]
  },
  "assays": [
    {
      "type": "transcription-profiling",
      "platform": "Illumina NovaSeq 6000",
      "qc": {
        "QA Instrument": "Agilent 4200 TapeStation",
        "Read Depth": "60696822",
        "rRNA Contamination": "0.59"
      },
      "library": {
        "Library Selection": "poly-A enrichment",
        "Library Layout": "SINGLE",
        "Library Kit": "NEXTFLEX Combo-Seq mRNA/miRNA Kit"
      },
      "files": {
        "raw": [
          "GLDS-694_rna-seq_GSM8078929_raw.fastq.gz",
          "GLDS-694_rna-seq_GSM8078930_raw.fastq.gz",
          "GLDS-694_rna-seq_GSM8078931_raw.fastq.gz",
          "GLDS-694_rna-seq_GSM8078932_raw.fastq.gz"
        ],
        "processed": [
          "GSM8078929",
          "GeneLab raw data processing protocol",
          "Agilent 4200 TapeStation",
          "poly-A enrichment",
          "SINGLE",
          "NEXTFLEX Combo-Seq mRNA/miRNA Kit",
          "Illumina NovaSeq 6000",
          "rna-seq",
          "76",
          "percent",
          "UO",
          "http://purl.obolibrary.org/obo/UO_0000187",
          "60696822",
          "0.59",
          "GSM8078930",
          "66955308",
          "0.47",
          "GSM8078931",
          "75061873",
          "0.73",
          "GSM8078932",
          "57202983",
          "0.53"
        ],
        "reports": [
          "GLDS-694_rna_seq_raw_multiqc_GLbulkRNAseq_report.zip"
        ]
      }
    }
  ]
}